Lung Cancer Clinical Trial
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
Stanford University School of Medicine
Stanford California, 94305, United States
Stanford California, 94305, United States
How clear is this clinincal trial information?